Grantham, Mayo, Van Otterloo & Co (GMO)
NVO

Grantham, Mayo, Van Otterloo & Co (GMO)’s Novo Nordisk NVO Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27,971
Closed -$1.03M – 705
2026
Q1 		$1.03M Sell
27,971
-157,000
-85% -$7.44M ﹤0.01% 505
2025
Q4 		$9.41M Buy
184,971
+108,359
+141% +$5.54M 0.02% 241
2025
Q3 		$4.25M Buy
76,612
+15,027
+24% +$880K 0.01% 303
2025
Q2 		$4.25M Buy
61,585
+23,968
+64% +$1.63M 0.01% 314
2025
Q1 		$2.61M Buy
+37,617
New +$3.11M 0.01% 359
2019
Q3 		– Sell
-1,466,360
Closed -$37.4M – 771
2019
Q2 		$37.4M Sell
1,466,360
-887,200
-38% -$21.9M 0.26% 67
2019
Q1 		$61.6M Buy
2,353,560
+351,600
+18% +$8.64M 0.44% 48
2018
Q4 		$46.1M Buy
2,001,960
+34,200
+2% +$760K 0.37% 54
2018
Q3 		$46.4M Buy
1,967,760
+604,706
+44% +$14.8M 0.31% 64
2018
Q2 		$31.4M Buy
1,363,054
+49,054
+4% +$1.17M 0.22% 68
2018
Q1 		$32.4M Buy
+1,314,000
New +$34.5M 0.2% 82
2016
Q4 		– Sell
-123,400
Closed -$2.57M – 535
2016
Q3 		$2.57M Sell
123,400
-51,800
-30% -$1.28M 0.01% 308
2016
Q2 		$4.71M Sell
175,200
-70,000
-29% -$1.92M 0.02% 297
2016
Q1 		$6.64M Buy
+245,200
New +$6.57M 0.02% 274

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s NVO Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 27,971 shares — an estimated $1.03M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NVO in Q1 2016 and held it in 14 quarters. The position peaked at $61.6M in Q1 2019. 1,352 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 27,971 Novo Nordisk shares in Q2 2026, an estimated $1.03M.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Novo Nordisk in Q1 2016 and held it in 14 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Novo Nordisk position peaked at $61.6M in Q1 2019.
  • 1,352 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.